Mixed cryoglobulinaemia vasculitis after sustained hepatitis C virological response with direct-acting antivirals

6Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Mixed cryoglobulinaemia (MCG) is one of the most severe extrahepatic hepatitis C virus (HCV)-associated complications, and could involve several organs, including the kidney. MCG prognosis relies on HCV response to antiviral treatment and has changed over the last years, especially after the introduction of new direct acting antivirals (DAA). MCG persistence despite sustained virological response (SVR) is uncommon and has a poorly known meaning and prognosis. We report a case of a patient with chronic HCV infection treated with DAA who developed MCG vasculitis despite the SVR.

Cite

CITATION STYLE

APA

Barbieri, D., García-Prieto, A., Torres, E., Verde, E., Goicoechea, M., & Luño, J. (2019). Mixed cryoglobulinaemia vasculitis after sustained hepatitis C virological response with direct-acting antivirals. Clinical Kidney Journal, 12(3), 362–364. https://doi.org/10.1093/ckj/sfy055

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free